| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2001 | US6180343 Green fluorescent protein fusions with random peptides |
| 01/30/2001 | US6180339 Nucleic acid probes for the detection and identification of fungi |
| 01/30/2001 | US6180336 Labelling and selection of molecules |
| 01/30/2001 | US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems |
| 01/30/2001 | US6180112 Pasteurella haemolytica vaccine |
| 01/30/2001 | US6180111 Vaccine delivery system |
| 01/30/2001 | US6180110 Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| 01/30/2001 | US6180109 Nucleotide and polypeptide sequences of pestivirus strains |
| 01/30/2001 | US6180107 Stimulating angiogenesis or wound healing through vascular repair, neovascularization, or both, by administering pharmaceutically effective amount of mammalian vascular endothelial growth factor ii factor |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180103 Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| 01/30/2001 | US6180098 Recombinant helicoverpa baculoviruses expressing heterologous DNA |
| 01/30/2001 | US6180097 For treatment of solid tumors, including their metastases, without radiation, surgery or standard chemotherapeutic by using superantigens, including staphyloccocal enterotoxins b and c, to stimulate tumor draining lymph node cells |
| 01/30/2001 | CA2313825A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/30/2001 | CA2177604C Labelling of nucleic acid analogue-peptide chimerae |
| 01/30/2001 | CA2139931C Purification of factor ix |
| 01/30/2001 | CA2132953C Monospecific polyclonal antibodies to shiga-like toxins |
| 01/30/2001 | CA2124458C Technetium-99m labeled peptides for imaging |
| 01/30/2001 | CA2101942C Technetium-99m labeled polypeptides for imaging |
| 01/30/2001 | CA2069337C Dna, constructs, cells and plants derived therefrom |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/30/2001 | CA2022610C Human gp130 protein |
| 01/30/2001 | CA1341174C Procoagulant proteins derived from factor viii: c |
| 01/25/2001 | WO2001006252A2 Prediction of hepatic failure following hepatitis c |
| 01/25/2001 | WO2001006226A2 Methods for determining the proliferation activity of cells |
| 01/25/2001 | WO2001006006A1 Environmental stress resistance gene |
| 01/25/2001 | WO2001005998A1 Follistatin-3 |
| 01/25/2001 | WO2001005997A2 Method for production of tetanus toxin using media substantially free of animal products |
| 01/25/2001 | WO2001005991A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005989A1 Method of constructing recombinant adenovirus vector |
| 01/25/2001 | WO2001005988A1 Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector |
| 01/25/2001 | WO2001005986A2 Mites-like element and transcriptional activation element |
| 01/25/2001 | WO2001005980A1 Compositions and methods for fumonisin detoxification |
| 01/25/2001 | WO2001005978A1 FimH ADHESIN-BASED VACCINES |
| 01/25/2001 | WO2001005977A1 Generation of stable dimers with reversible biotin-binding activity |
| 01/25/2001 | WO2001005976A1 Mutated ribosomal protein l3 |
| 01/25/2001 | WO2001005975A1 MAIZE ORTHOLOGUES OF BACTERIAL RuvB:cDNAS AND USES THEREOF |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005973A1 Macaca cynomolgus il18 |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005971A2 Secreted polypeptides and corresponding polynucleotides |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005968A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/25/2001 | WO2001005967A1 Splice variants of cd40-receptor |
| 01/25/2001 | WO2001005966A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 01/25/2001 | WO2001005965A1 Non-human mammal with tissue specific modified glucocorticoid receptor |
| 01/25/2001 | WO2001005964A1 Inhibitor of osteoclast precursor formation |
| 01/25/2001 | WO2001005957A2 Grapevine leafroll-associated virus proteins |
| 01/25/2001 | WO2001005953A2 Maize ethylene signalling pathway ein3 genes and uses thereof |
| 01/25/2001 | WO2001005952A2 Plant genes |
| 01/25/2001 | WO2001005951A2 Novel sgs3 plant gene and use thereof |
| 01/25/2001 | WO2001005950A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005946A1 Model for studying the evolution of spontaneous pulmonary metastases, and use for screening medicines |
| 01/25/2001 | WO2001005945A2 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/25/2001 | WO2001005934A2 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 01/25/2001 | WO2001005836A1 Polypeptidic compositions and methods for the treatment of tumors |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005833A1 Odorant receptors |
| 01/25/2001 | WO2001005832A1 Drug target isogenes: polymorphisms in the dopamine receptor d2 gene |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005830A1 Dna encoding orphan snorf40 receptor |
| 01/25/2001 | WO2001005829A1 Receptor |
| 01/25/2001 | WO2001005828A1 Novel human calcium sensitive potassium channel subunits |
| 01/25/2001 | WO2001005827A1 Fima PILUS-BASED VACCINES |
| 01/25/2001 | WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | WO2001005825A2 Nucleic acid sequences encoding putative angiopoietin proteins |
| 01/25/2001 | WO2001005824A2 Synthetic peptides immunoreactive with hepatitis a virus antibodies |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005822A2 Molecules derived from interleukin-1 beta |
| 01/25/2001 | WO2001005820A2 Method for down-regulating gdf-8 activity |
| 01/25/2001 | WO2001005812A2 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING α3β1 INTEGRINS |
| 01/25/2001 | WO2001005809A1 Method for carrying out the chromatographic fractionation of plasma or serum, preparations obtained thereby and their use |
| 01/25/2001 | WO2001005804A1 Novel genes associated with renal disease |
| 01/25/2001 | WO2001005803A1 NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE |
| 01/25/2001 | WO2001005757A2 Process for the deprotection of protected thiols |
| 01/25/2001 | WO2001005480A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 01/25/2001 | WO2001005437A2 Methods for treatment of hyperproliferative diseases using human mda-7 |
| 01/25/2001 | WO2001005427A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | WO2001005426A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | WO2001005422A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | WO2001005419A2 Agent for treating cardiac diseases |
| 01/25/2001 | WO2001005418A2 Tissue regenerating agent |
| 01/25/2001 | WO2001005353A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 01/25/2001 | WO2001005222A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 01/25/2001 | WO2000071576A3 Adenovirus vectors encoding brain natriuretic peptide |
| 01/25/2001 | WO2000071566A3 Novel organic anion transport proteins |
| 01/25/2001 | WO2000066742A3 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
| 01/25/2001 | WO2000065034A3 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/25/2001 | WO2000064930A3 Tribonectins |
| 01/25/2001 | WO2000064928A3 Transmembrane (7tm) receptor r35) |
| 01/25/2001 | WO2000063357A3 Methods and compositions for modulating ciliary neurotrophic factor activity |
| 01/25/2001 | WO2000062065B1 Complex formed by n-linked glycoproteins (siblings) and factor h |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000059940A3 Platelet-derived growth factor related gene and protein |
| 01/25/2001 | WO2000058486A3 Maize ku80 homolog and uses thereof |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |